Articles with public access mandates - Ramona CurpanLearn more
Not available anywhere: 2
Off-patent drug repositioning
S Avram, R Curpan, L Halip, A Bora, TI Oprea
Journal of chemical information and modeling 60 (12), 5746-5753, 2020
Mandates: US National Institutes of Health
Cheminformatics Data Mining and Modeling for Drug Repurposing
S Avram, R Curpan, TI Oprea
Mandates: US National Institutes of Health
Available somewhere: 26
DrugCentral 2021 supports drug discovery and repositioning
S Avram, CG Bologa, J Holmes, G Bocci, TB Wilson, DT Nguyen, ...
Nucleic acids research 49 (D1), D1160-D1169, 2021
Mandates: US National Science Foundation, US National Institutes of Health
A crowdsourcing evaluation of the NIH chemical probes
TI Oprea, CG Bologa, S Boyer, RF Curpan, RC Glen, AL Hopkins, ...
Nature chemical biology 5 (7), 441-447, 2009
Mandates: US National Institutes of Health
The selective estrogen receptor modulator bazedoxifene inhibits hormone-independent breast cancer cell growth and down-regulates estrogen receptor α and cyclin D1
JS Lewis-Wambi, H Kim, R Curpan, R Grigg, MA Sarker, VC Jordan
Molecular pharmacology 80 (4), 610-620, 2011
Mandates: US National Institutes of Health
Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells
S Sengupta, I Obiorah, PY Maximov, R Curpan, VC Jordan
British journal of pharmacology 169 (1), 167-178, 2013
Mandates: US National Institutes of Health
Structure− function relationships of estrogenic triphenylethylenes related to endoxifen and 4-hydroxytamoxifen
PY Maximov, CB Myers, RF Curpan, JS Lewis-Wambi, VC Jordan
Journal of medicinal chemistry 53 (8), 3273-3283, 2010
Mandates: US National Institutes of Health
Highly efficient synthesis and characterization of the GPR30-selective agonist G-1 and related tetrahydroquinoline analogs
R Burai, C Ramesh, M Shorty, R Curpan, C Bologa, LA Sklar, T Oprea, ...
Organic & biomolecular chemistry 8 (9), 2252-2259, 2010
Mandates: US National Institutes of Health
Estrogen receptor mutations found in breast cancer metastases integrated with the molecular pharmacology of selective ER modulators
VC Jordan, R Curpan, PY Maximov
Journal of the National Cancer Institute 107 (6), djv075, 2015
Mandates: Susan G. Komen
Detection of intracellular granularity induction in prostate cancer cell lines by small molecules using the HyperCyt® high-throughput flow cytometry system
MK Haynes, JJ Strouse, A Waller, A Leitao, RF Curpan, C Bologa, ...
SLAS Discovery 14 (6), 596-609, 2009
Mandates: US National Institutes of Health
The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy
P Fan, PY Maximov, RF Curpan, B Abderrahman, VC Jordan
Molecular and cellular endocrinology 418, 245-263, 2015
Mandates: US National Institutes of Health, Susan G. Komen
Endoxifen, 4-hydroxytamoxifen and an estrogenic derivative modulate estrogen receptor complex mediated apoptosis in breast cancer
PY Maximov, B Abderrahman, SW Fanning, S Sengupta, P Fan, ...
Molecular pharmacology 94 (2), 812-822, 2018
Mandates: US Department of Defense, US National Institutes of Health, Susan G. Komen
Structural determinants of the alpha2 adrenoceptor subtype selectivity
L Ostopovici-Halip, R Curpăn, M Mracec, CG Bologa
Journal of Molecular Graphics and Modelling 29 (8), 1030-1038, 2011
Mandates: US National Institutes of Health
Defining the conformation of the estrogen receptor complex that controls estrogen-induced apoptosis in breast cancer
I Obiorah, S Sengupta, R Curpan, VC Jordan
Molecular pharmacology 85 (5), 789-799, 2014
Mandates: US National Institutes of Health, Susan G. Komen
DrugCentral 2023 extends human clinical data and integrates veterinary drugs
S Avram, TB Wilson, R Curpan, L Halip, A Borota, A Bora, CG Bologa, ...
Nucleic acids research 51 (D1), D1276-D1287, 2023
Mandates: US National Institutes of Health
High-throughput screen for the chemical inhibitors of antiapoptotic bcl-2 family proteins by multiplex flow cytometry
RF Curpan, PC Simons, D Zhai, SM Young, MB Carter, CG Bologa, ...
Assay and drug development technologies 9 (5), 465-474, 2011
Mandates: US National Institutes of Health
A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers
PY Maximov, B Abderrahman, RF Curpan, YM Hawsawi, P Fan, ...
Endocrine-related cancer 25 (2), R83-R113, 2018
Mandates: US National Institutes of Health, Susan G. Komen
Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients
PY Maximov, RE McDaniel, DJ Fernandes, P Bhatta, VR Korostyshevskiy, ...
Journal of the National Cancer Institute 106 (10), dju283, 2014
Mandates: US National Institutes of Health, Susan G. Komen
The structure-function relationship of angular estrogens and estrogen receptor alpha to initiate estrogen-induced apoptosis in breast cancer cells
PY Maximov, B Abderrahman, YM Hawsawi, Y Chen, CE Foulds, A Jain, ...
Molecular pharmacology 98 (1), 24-37, 2020
Mandates: US Department of Energy, US Department of Defense, US National Institutes of …
The conformation of the estrogen receptor directs estrogen-induced apoptosis in breast cancer: a hypothesis
P Maximov, S Sengupta, JS Lewis-Wambi, HR Kim, RF Curpan, ...
Hormone molecular biology and clinical investigation 5 (1), 27-34, 2011
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program